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Abstract
Background: Research in 2007 showed that World Health Organization (WHO) recommendations were largely based on
expert opinion, rarely used systematic evidence-based methods, and did not follow the organization’s own ‘‘Guidelines for
Guidelines’’. In response, the WHO established a ‘‘Guidelines Review Committee’’ (GRC) to implement and oversee
internationally recognized standards. We examined the impact of these changes on WHO guideline documents and
explored senior staff’s perceptions of the new procedures.
Methods and Findings: We used the AGREE II guideline appraisal tool to appraise ten GRC-approved guidelines from nine
WHO departments, and ten pre-GRC guidelines matched by department and topic. We interviewed 20 senior staff across 16
departments and analyzed the transcripts using the framework approach. Average AGREE II scores for GRC-approved
guidelines were higher across all six AGREE domains compared with pre-GRC guidelines. The biggest changes were noted
for ‘‘Rigour of Development’’ (up 37.6%, from 30.7% to 68.3%) and ‘‘Editorial Independence’’ (up 52.7%, from 20.9% to
73.6%). Four main themes emerged from the interviews: (1) high standards were widely recognized as essential for WHO
credibility, particularly with regard to conflicts of interest; (2) views were mixed on whether WHO needed a single quality
assurance mechanism, with some departments purposefully bypassing the procedures; (3) staff expressed some
uncertainties in applying the GRADE approach, with departmental staff concentrating on technicalities while the GRC
remained concerned the underlying principles were not fully institutionalized; (4) the capacity to implement the new
standards varied widely, with many departments looking to an overstretched GRC for technical support.
Conclusions: Since 2007, WHO guideline development methods have become more systematic and transparent. However,
some departments are bypassing the procedures, and as yet neither the GRC, nor the quality assurance standards they have
set, are fully embedded within the organization.
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Introduction
The World Health Organization (WHO) is a leading producer
of healthcare recommendations, guiding and informing policy
worldwide, particularly for low and middle income countries.
Research published in 2007 however demonstrated that WHO
recommendations were based mainly on expert opinion and rarely
used systematic evidence-based methods [1]. Internal ‘Guidelines
for Guidelines’ were in place since 2003, but the organization
lacked an effective mechanism to enforce the expected standards
[2–4].
This public criticism prompted the WHO to establish a
‘Guidelines Review Committee’ (GRC), composed of both internal
staff and external advisors, tasked with implementing and
overseeing quality assurance [5]. The GRC re-established a set
of guideline development standards and adopted the GRADE
(Grading of Recommendations Assessment, Development and
Evaluation) approach to formulating evidence-based recommen-
dations [6]. Supported by a small secretariat, the GRC now
expects to review new and updated guideline proposals at the
planning stage and again before publication [7]. In this paper we
evaluate WHO guideline documents against international stan-
dards pre and post formation of the GRC, and explore senior
staff’s perceptions of the GRC and the new procedures.
Methods
Ethics statement
The study protocol was discussed with both the Liverpool
School of Tropical Medicine Ethics Committee and the WHO
Ethics Review Committee and received a formal written waiver.
Permission to conduct the study was granted by the Assistant
Director General of the WHO. All participants in the study
provided written informed consent prior to being interviewed.
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Guideline appraisal
We sampled WHO guidelines, pre- and post-GRC, from a
spread of WHO departments and across a range of broad topic
areas (prevention, diagnosis, treatment, and health systems), using
a ‘matched’ before-and-after study design.
To fully evaluate the impact of the changes we chose guidelines
published online during 2010 as the initial post-GRC sampling
frame (most guidelines published in 2008/09 only partially
implemented the changes as they were already in progress prior
to the establishment of the GRC). We randomly selected one
guideline from each department that published during 2010, and
matched this with a pre-GRC guideline from the same department
and broad topic area. Where possible this match was with an
earlier edition of the same document.
We used the AGREE II appraisal tool to assess the methods and
presentation of each guideline using 23 criteria across six domains:
scope and purpose, stakeholder involvement, rigour of develop-
ment, clarity of presentation, applicability, and editorial indepen-
dence [8]. AGREE II provides extensive explanatory notes for
each criterion to guide the appraisal and improve consistency
across reviewers [9].
All four assessors (DS, RI, TK and BZ) completed the AGREE
II online training modules prior to beginning the study, and to
improve standardization, one guideline was appraised and
discussed extensively by all four. Each guideline was allocated
randomly to two assessors who worked independently but were not
blinded to the year of publication. Each assessor initially allocated
a score between 1 and 7 for each criterion, and scores were then
aggregated across assessors and converted to a percentage for each
domain. Wide disagreement in scores was resolved by a third
assessor.
DS and PG, who have participated in the development of
guidelines in malaria, were excluded from appraising guidelines
from the Global Malaria Programme.
WHO staff interviews
We interviewed senior staff from 18 WHO departments,
representing departments experienced with publishing GRC-
approved guidelines, others who had not yet been through the
process, the GRC chair and members of the secretariat. The GRC
secretariat assisted in this selection process to ensure a spread of
‘supporters and opponents’. Following written informed consent,
each person was interviewed by two researchers (PG and DS) in
April 2012 using a topic guide (Appendix S1). Interviews were
audio-recorded and fully transcribed. We used framework analysis
to develop a thematic framework which we used to code and
organise the data and, through an iterative process with regular
discussion, we assembled related codes to form the main themes
[10]. The initial draft manuscript was distributed to all participants
for comment and correction of factual error or interpretation.
Results
Guideline appraisal
Seventeen GRC-approved guidelines were published online in
2010, from nine different WHO departments spread across six
departmental clusters. Of note, four were published by the HIV
department and five by STOP TB. From these seventeen, ten
were selected for formal appraisal: one from each of the nine
departments and one additional guideline from the HIV
department as it was the only guideline addressing diagnostic
questions. Five guidelines addressed questions about treatment,
two about safety or illness prevention, and two provided health
system guidance.
The ten matched guidelines were published between 2003 and
2008 by the same nine WHO departments, all pre-dating the
GRC approval process. Of these, five were earlier editions of the
same guideline and five were earlier guidelines addressing a similar
topic area.
Mean scores for all six domains of the AGREE II appraisal were
higher in the ten GRC-approved guidelines than in the ten older
‘matched’ guidelines (Table 1; full assessments in Appendix S2).
Seven of the matched pairs showed substantial improvement
against almost all the criteria, while three made little improvement
or declined.
‘Rigour of Development’ and ‘Editorial Independence’ were the
lowest scoring domains across the pre-GRC guidelines with eight
out of ten guidelines scoring less than 40% for both domains.
Substantial improvements were seen in seven of the GRC-
approved guidelines, with eight of the ten guidelines now scoring
greater than 60% for both domains. ‘Stakeholder Involvement’
and ‘Applicability’ were now the lowest scoring domains in GRC-
approved guidelines.
During the research we identified two additional documents
which had bypassed the GRC process, and were informed that
one guideline group had a formal ‘waiver’ on the GRC process.
An AGREE II appraisal of these three documents gave scores
similar to pre-GRC guidelines (Appendix S3).
Interviews with senior staff
The 20 interviews were conducted with ten heads of depart-
ments (Directors), seven senior technical staff who had been
involved with guideline development (Co-ordinators, Medical
Officers and Technical Officers), and three others directly involved
with the GRC. Through careful analysis of the content of these
interviews we identified four main themes (Table 2).
1) High standards are essential for WHO credibility
(Table S1). Most directors acknowledged that the criticism
levelled at the organization in 2007 was fair and that many WHO
guidelines and recommendations published prior to this were of
low quality.
Some noted that these deficiencies were not universal and gave
examples of evidence-based systematic processes in use well before
the GRC. These interviewees viewed the recent changes in process
as relatively minor for them but essential for raising standards
across the organization.
Senior staff widely recognized the normative role of the WHO
as central to its mission, and guidelines as one of the most visible
products on which the organization is judged. High standards
were noted as important by interviewees to defend the WHO
against criticism (particularly with regard to conflicts of interest); to
improve the reliability of recommendations; and to ensure the
future credibility and position of the organization.
2) Mixed views on the need for a single quality assurance
mechanism (Table S2). While the interviewees universally
advocated high standards, opinions were mixed on the need for a
single quality assurance mechanism across the organization, with
some questioning the power given to the current GRC.
One director expressed strong opinions against the GRC and
against a perceived loss of autonomy, describing the process as a
‘‘monstrous bureaucracy’’; citing negative early experiences with
the GRC, and scepticism from external members of guideline
panels. Another director questioned whether the GRC should
have the power to block documents at either the planning or
publication stage, and whether the GRC had the technical
capacity to make such a judgement.
Others were very positive about the GRC, its influence, and
how it had helped them. Some admitted to similar initial concerns
Evaluation of WHO Guidelines
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– of fear about the ‘guideline police’ delaying and unnecessarily
complicating the process – but through positive experiences now
viewed the GRC as a valuable resource and essential as one of the
few quality assurance mechanisms within the WHO.
Representatives of the GRC reported constructive partnerships
with many departments but raised examples of groups bypassing
the GRC process, either by ‘‘game-playing’’ (calling the document
a policy brief or meeting report instead of a guideline) or wilfully
through disregard for the GRC and the procedures.
3) Uncertainties about applying the GRADE approach
(Table S3). Several areas of uncertainty relating to the GRADE
approach were noted. While departmental staff tended to
concentrate on discussing the technicalities and bureaucracy of
the process, those from the GRC emphasised the general
principles underlying a transparent, systematic, and explicit
process, and remained concerned that even these were not yet
fully institutionalized.
Most interviewees agreed that the GRADE approach to
assessing quality of evidence worked well for clinical questions
and recommendations, but some were uncertain about whether
these methods could be used for health systems or implementation
guidance. However, we did hear one example of a group using
Table 1. AGREE II scores for guidelines published pre and post formation of the GRC.1
Mean scores3 (%)
Pre GRC2 Post GRC2
AGREE II domain (n =10) (n =10) Mean difference (%)
Median
change in
domain
score (%) Range
Scope and Purpose4 62.2 80.4 +18.2 +12.5 23 to +39
Stakeholder Involvement5 49.8 61.2 +11.4 +18.0 233 to +47
Rigour of Development6 30.7 68.3 +37.6 +53.5 226 to +76
Clarity of Presentation7 60.9 78.2 +17.3 +23 247 to +52
Applicability8 49.1 61.6 +12.5 +16.5 222 to +65
Editorial Independence9 20.9 73.6 +52.7 +67 221 to +92
1Three additional guidelines were appraised, published since 2010 but known to have bypassed or not used the GRC approval process. These documents scored at
levels similar to the pre-GRC guidelines and can be seen in Appendix S3.
2Each guideline was appraised by at least two assessors working independently and the individual scores aggregated.
3Mean scores were calculated across all ten guidelines for each domain.
4Scope and purpose concerns the overall aim of the guideline, the scope of the questions, and the target audience.
5Stakeholder involvement looks at the extent to which the guideline development process included the views of all appropriate stakeholders, including the intended
users of the guideline and those affected by the recommendations.
6Rigour of development examines the process used to search for, synthesize, and appraise evidence, formulate recommendations, and keep them updated.
7Clarity of presentation concerns the general language, structure, and format of the guideline.
8Applicability requires adequate consideration of the likely barriers and facilitators to implementation, including resource considerations, and advice or tools to improve
uptake and implementation.
9Editorial independence concerns the adequate declaration and management of potential conflicts of interest related to the funding body or the guideline group
members.
doi:10.1371/journal.pone.0063715.t001
Table 2. Four key emergent themes.
1. High standards essential for credibility
The normative role of the WHO was widely recognised as a core function and guidelines as one of the most visible products. High standards were considered essential
for defending the WHO against criticism, particularly with regard to conflicts of interest.
2. Mixed views on the need for a single quality assurance process
While the senior directors universally advocated for high standards, opinions were mixed on the need for a single quality assurance process across the organization.
Some questioned the power given to the current GRC and some purposefully avoided the process, while others now viewed it as a valuable resource and an essential
mechanism for the organization.
3. Uncertainties about applying the GRADE approach
Several uncertainties relating to the GRADE approach were noted. While departmental staff tended to concentrate on discussing the technicalities and bureaucracy of
GRADE, those from the GRC emphasized the general principles underlying a transparent, systematic, and explicit process, and remained concerned that even these were
not yet fully institutionalized.
4. Technical capacity to implement the new standards is variable
Many who had been through the GRC process described it as a steep learning curve, both for them and for the external experts who were often equally unfamiliar with
these methods. It was clear that many departments were looking to the GRC to provide technical support alongside quality assurance and the GRC themselves
expressed the lack of both financial and personnel capacity to do this.
doi:10.1371/journal.pone.0063715.t002
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GRADE for a health systems guideline with enthusiasm. This
group felt the additional efforts had increased the clarity and
usefulness of their recommendations.
Some interviewees discussed uncertainties about how to apply
the GRADE approach when the evidence was of very low quality
or when the recommendation seemed obviously ‘common sense’.
In these instances, some felt forced to search for evidence when it
was considered unhelpful or necessarily time-consuming. Some
also expressed concerns that if applied wrongly, a formulaic
approach to GRADE could mislead or detract people from
addressing the right questions with the most appropriate methods,
and lead to poorly thought-out documents, or ill-advised
recommendations.
Many of the interviewees acknowledged that making recom-
mendations that were intended to inform policies in many
different settings was not straightforward: disease burden, health
infrastructure and financing, and cultural values and preferences
are all different and need to be taken into account. There was
uncertainty about how to incorporate these considerations into
WHO documents or how to provide the necessary contextual
guidance within the framework of existing methods.
4) Variable capacity to implement the new standards
(Table S4). Many who had been through the GRC approval
process described it as a steep learning curve, both for them and
for the external experts who were often equally unfamiliar with
these methods. Several directors and technical staff had attended
educational sessions conducted by the GRC and valued these
highly.
Some senior staff stated that the technical expertise to apply
these new methods was not widespread within the organization
and others admitted that their progress so far had been reliant on
just one or two highly skilled individuals within the department.
Some however, appeared fully engaged in the process, were
talking with the GRADE working group, and seemed keen to
further improve the methods for application to global guidelines.
Several directors had hired new staff with the specific skills
required to implement the procedures and prepare the documents.
Some reported that GRC members had provided useful method-
ological input to the expert meetings and some had brought in
external GRADE methodologists to sit on the expert panels. A few
directors did not seem to understand the concept of ‘guideline
methodology’ and were content to rely on the statistical
understanding of existing expert members who were usually
academic researchers or content experts.
While some departments seemed to be having difficulty fitting
the requirements of the GRC methods around the existing
framework of long-established expert groups or committees, others
appeared more innovative, readily disbanding such groups and
finding new ways to garner expert advice at appropriate stages of
the process.
Discussion
Four years after the GRC was formed, our AGREE II
evaluation demonstrates that the transparency of WHO guidelines
processes has improved and the organization is making wider use
of systematic evidence appraisal. However, we found wide
differences between groups in their capacity to implement these
changes and in their willingness to participate in the GRC
procedures; with some groups embracing it enthusiastically, some
bypassing it, and some simply rejecting it.
The AGREE II appraisal has several limitations. Firstly, the
AGREE II tool is unable to fully assess the ‘appropriateness’ of the
final recommendations or ‘use-ability’ of the final document –
both highly important considerations. Despite this, reporting of
funding sources, conflicts of interests, and guideline methodology
are considered minimum standards internationally and are
essential to the future credibility of the organization [11].
Secondly, the study is susceptible to bias as the assessors were
not blinded to year of publication. This is unlikely to fully explain
the findings however, as the changes are both large and involve
clearly identifiable items. For example; within the majority of
matched pairs there was transition from almost complete absence
of a methods section in the pre-GRC guideline to a fairly complete
description in the GRC-approved document. Despite the small
sample size, this study therefore provides fairly robust evidence of
change within some guideline groups. Thirdly, the uncontrolled
nature of the study is unable to prove that the observed changes
are a result of the GRC. Other factors may also be important, such
as an increased involvement of guideline methodologists on WHO
panels, a change in attitudes of WHO department directors as a
result of the external criticism, and simply a gradual improvement
over time. However, from the interviews with staff members it is
clear that many within the organization consider the GRC
secretariat and committee to be major players in overseeing,
facilitating, and enforcing this change.
From our own experience and understanding of the GRADE
approach, the concerns raised during the interviews seem to relate
to poor understanding of the process and a lack of embedded
institutional capacity, rather than deficiencies in the methods
themselves. Effective use of the GRADE approach requires high
quality, well-constructed systematic reviews, followed by critical
and thoughtful analysis and interpretation of the data by the
guideline panels, both of which can prolong and complicate the
guideline development process without adequate planning and in-
house technical capacity. Difficulties such as ‘common-sense’
recommendations are common across guideline developers and
have been addressed elsewhere by the GRADE Working Group
[12]. On the other hand, developing global guidelines for widely
differing settings and systems entail challenges that are less
common. Many guideline groups have brought in external
guideline specialists, who are perhaps uniquely placed to offer
insights into the difficulties encountered with using GRADE and
to suggest appropriate solutions to continuing this improvement
process. Their opinions would be extremely valuable in providing
insight into how the organization is learning and how to further
institutionalise this process. Indeed, the WHO could take a
leadership role in collaboration with their methodological partners
in advancing appropriate methods in guideline development.
At present, the GRC itself appears fragile and the procedures it
has put in place could yet be derailed by departments wanting to
do things their own way. Indeed, some interviewees recounted the
near collapse of the GRC in late 2010/11 through mismanage-
ment, and it is a credit to the organization that it has survived.
Conclusions
WHO procedures for developing guidelines have improved
considerably since the GRC was established, with wider use of
systematic methods, improved transparency and better manage-
ment of potential conflicts of interest. The interviews with senior
WHO staff support the conclusion that a large part of these
improvements can be attributed to the GRC.
However, as yet neither the GRC, nor the changes implement-
ed by them, are fully embedded within the organization. Political
support and greater resourcing are required to institutionalize the
principles and procedures, and move forward with further
improvements.
Evaluation of WHO Guidelines
PLOS ONE | www.plosone.org 4 May 2013 | Volume 8 | Issue 5 | e63715
Supporting Information
Appendix S1 Draft Interview Guide.
(DOCX)
Appendix S2 Full AGREE II appraisal scores for pre-
and post-GRC guidelines.
(DOCX)
Appendix S3 AGREE II appraisal scores for three recent
guidelines that did not seek GRC approval.
(DOCX)
Table S1 Theme 1: High standards essential for
credibility.
(DOCX)
Table S2 Theme 2: Mixed views on the need for a single
quality assurance process.
(DOCX)
Table S3 Theme 3: Uncertainties about applying the
GRADE methods.
(DOCX)
Table S4 Theme 4: Variable capacity to implement the
new standard.
(DOCX)
Acknowledgments
The authors would like to thank all the staff at the WHO for their
willingness to participate, their openness in the dialogue, and their help at
all levels in this evaluation.
Author Contributions
Conceived and designed the experiments: DS RI TK BZ HS PG.
Performed the experiments: DS RI TK BZ PG. Analyzed the data: DS TK
BZ PG. Wrote the paper: DS RI TK BZ HS PG.
References
1. Oxman AD, Lavis JN, Fretheim A (2007) Use of evidence in WHO
recommendations. Lancet 369: 1883–1889.
2. WHO (2003) Guidelines for WHO Guidelines. WHO Press, World Health
Organization, Geneva Available: http://whqlibdoc.who.int/hq/2003/EIP_
GPE_EQC_2003_1.pdf. Accessed August 2012.
3. Oxman AD, Fretheim A, Schu¨nemann HJ, SURE (2006) Improving the use of
research evidence in guideline development: introduction. Health Res Policy
Syst 4: 12.
4. Schu¨nemann HJ, Fretheim A, Oxman AD, WHO Advisory Committee on
Health Research (2006) Improving the use of research evidence in guideline
development: 1. Guidelines for guidelines. Health Res Policy Syst 4: 13.
5. Hill S, Pang T (2007) Leading by example: a culture change at WHO. Lancet
369(9576): 1842–1844.
6. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, et al. (2008)
GRADE: an emerging consensus on rating quality of evidence and strength of
recommendations. BMJ 336(7650): 924–926.
7. WHO (2012) WHO Handbook for Guideline Development. WHO Press, World
Health Organization, Geneva. Available: http://apps.who.int/iris/bitstream/
10665/75146/1/9789241548441_eng.pdf. Accessed August 2012.
8. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, et al. (2010)
AGREE II: Advancing guideline development, reporting and evaluation in
healthcare. CMAJ 182(18): E839–842.
9. AGREE (2009) The AGREE II Instrument. Available: http://www.agreetrust.
org/about-agree/introduction0/. Accessed August 2012.
10. Ritchie J, Spencer L, O’Connor W (2003) Carrying out analysis. In: Ritchie J,
Lewis J, editors. Qualitative research practice: a guide for social science students
and researchers. London: Sage Publications Ltd. 219–262.
11. Qaseem A, Forland F, Macbeth F, Ollenschlager G, Phillips S, et al. (2012)
Guidelines International Network: toward international standards for clinical
practice guidelines. Ann Intern Med 156(7): 525–531.
12. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, et al. (2011) GRADE
guidelines 1. Introduction – GRADE evidence profiles and summary of findings
tables. J Clin Epidemiol 64(4): 383–394.
Evaluation of WHO Guidelines
PLOS ONE | www.plosone.org 5 May 2013 | Volume 8 | Issue 5 | e63715
